关注
Engin Yapici
Engin Yapici
Associate Director of Drug Discovery R&D
在 absci.com 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Lanthanide-based imaging of protein–protein interactions in live cells
M Rajendran, E Yapici, LW Miller
Inorganic chemistry 53 (4), 1839-1853, 2014
882014
Evaluation and discrimination of simvastatin-induced structural alterations in proteins of different rat tissues by FTIR spectroscopy and neural network analysis
S Garip, E Yapici, NS Ozek, M Severcan, F Severcan
Analyst 135 (12), 3233-3241, 2010
442010
Antibody optimization enabled by artificial intelligence predictions of binding affinity and naturalness
S Bachas, G Rakocevic, D Spencer, AV Sastry, R Haile, JM Sutton, ...
BioRxiv, 2022.08. 16.504181, 2022
402022
Unlocking de novo antibody design with generative artificial intelligence
A Shanehsazzadeh, S Bachas, M McPartlon, G Kasun, JM Sutton, ...
bioRxiv, 2023.01. 08.523187, 2023
252023
Automated design of macrocycles for therapeutic applications: from small molecules to peptides and proteins
D Sindhikara, M Wagner, P Gkeka, S Güssregen, G Tiwari, G Hessler, ...
Journal of Medicinal Chemistry 63 (20), 12100-12115, 2020
212020
An Adaptable Luminescence Resonance Energy Transfer Assay for Measuring and Screening Protein–Protein Interactions and their Inhibition.
E Yapici, DR Reddy, LW Miller
ChemBioChem 13 (4), 553-558, 2012
132012
Time-Gated Luminescence Detection for High-Throughput Screening of Protein Interaction and Inhibitions
E Yapici
University of Illinois at Chicago, 2015
12015
Discovery of novel, potent USP7 inhibitors that upregulate p53 leading to anti-proliferative effects in cancer cells
A Futran, T Lu, K Amberg-Johnson, X Yang, S He, J Bell, S Boyce, ...
Cancer Research 81 (13_Supplement), 1338-1338, 2021
2021
Cover Picture: An Adaptable Luminescence Resonance Energy Transfer Assay for Measuring and Screening Protein–Protein Interactions and their Inhibition.(ChemBioChem 4/2012)
E Yapici, DR Reddy, LW Miller
ChemBioChem 13 (4), 489-489, 2012
2012
系统目前无法执行此操作,请稍后再试。
文章 1–9